GraniteShares 2x Long LCID Daily ETF

📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Lucid(LCID.US) Lucid Group Names Eric Muller CEO to Lead Next Phase of Growth

👉 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:

➤ 𝗘𝗿𝗶𝗰 𝗠𝘂𝗹𝗹𝗲𝗿 joins 𝗟𝘂𝗰𝗶𝗱 𝗚𝗿𝗼𝘂𝗽 as Chief Executive Officer.

➤ 𝗥𝗶𝗰𝗸 𝗦𝗮𝗻𝗻𝗲𝗺 transitions from CEO to Strategic Advisor.

➤ Muller brings more than 𝟮𝟱 𝘆𝗲𝗮𝗿𝘀 of healthcare commercialisation experience.

➤ Muller previously served as 𝗣𝘂𝗯𝗹𝗶𝗰𝗶𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 Group President and COO.

➤ He previously held the role of President at 𝗗𝗶𝗴𝗶𝘁𝗮𝘀 𝗛𝗲𝗮𝗹𝘁𝗵.

➤ Leadership transition supports Lucid's next phase of 𝗴𝗹𝗼𝗯𝗮𝗹 𝗴𝗿𝗼𝘄𝘁𝗵.

➤ Muller will prioritize 𝘁𝗮𝗹𝗲𝗻𝘁, client partnerships, data, and technology capabilities.

➤ Lucid plans to strengthen 𝗔𝗜 and data capabilities across healthcare commercialisation.

➤ Sannem will continue supporting Lucid through its 𝗕𝗼𝗮𝗿𝗱 advisory role.

👉 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀:

➤ Leadership change signals Lucid's push toward accelerated 𝗴𝗹𝗼𝗯𝗮𝗹 𝗲𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻.

➤ Muller's experience could strengthen Lucid's healthcare 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻 capabilities.

➤ Greater 𝗔𝗜 and data investment could enhance client offerings.

➤ Sannem's advisory role provides continuity during the 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 transition.

👉 𝗘𝘅𝗽𝗲𝗿𝘁 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁𝘀:

𝗗𝗿 𝗥𝗼𝗱 𝗠𝗮𝗰𝗞𝗲𝗻𝘇𝗶𝗲, CMG, Chair, Lucid Group Board:

"Lucid works across the full arc of product commercialisation, from the earliest stages of clinical development to market launch and on through to loss of exclusivity. Eric understands how hard it can be for great science to break through but also how to commercialise healthcare at scale,"

"Our Board is grateful for Rick's vision and entrepreneurial stewardship that built Lucid's culture of delivering client success and pleased that he will continue to support us as we enter our next chapter."

𝗘𝗿𝗶𝗰 𝗠𝘂𝗹𝗹𝗲𝗿, Chief Executive Officer, Lucid Group:

"Healthcare is entering a new era, driven by extraordinary advances in science, data, and technology. Clients increasingly need a partner that turns complexity into clarity and impact by bringing together scientific expertise, creativity, and strategy, along with the power of data and AI. As data multiplies and development accelerates, knowing which evidence matters and what creative output will persuade is the part that becomes critical,"

"That is the future of healthcare marketing, and it is where Lucid is positioned to lead. I am a builder at heart, and I came to Lucid to build a business that helps clinicians, patients, and caregivers make better decisions about the things that matter most."

𝗥𝗶𝗰𝗸 𝗦𝗮𝗻𝗻𝗲𝗺, Strategic Advisor to Lucid's Board of Directors:

"Years ago, we made a deliberate decision to build an independent business that brings specialised commercialisation services together under one roof to best serve healthcare and pharma clients and that's exactly what Lucid has become,"

"I'm proud of the culture and standard of excellence we've built, and Eric's track record as a hands-on, transformative leader makes him the right person to lead Lucid into its next chapter of growth."